Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report

被引：0

作者：

Enrique Rey

Fermín Mearin

Javier Alcedo

Constanza Ciriza

Silvia Delgado-Aros

Teresa Freitas

Miguel Mascarenhas

Miguel Mínguez

Javier Santos

Jordi Serra

机构：

[1] Hospital Universitario Clínico de San Carlos,Division of Digestive Diseases

[2] Instituto de Investigacion San Carlos (IdISSC),Department of Medicine

[3] School of Medicine,Institute of Functional and Motor Digestive Disorders

[4] Complutense University,Division of Digestive Diseases

[5] Centro Médico Teknon,Division of Digestive Diseases

[6] Hospital Universitario Miguel Servet,Institut Hospital del Mar d’Investigacions Mèdiques (IMIM)

[7] Hospital Universitario Doce de Octubre,Division of Digestive Diseases

[8] Neuro-Enteric Translational Science (NETS) Research Group,Digestive System Research Unit, Laboratory of Neuro

[9] Centro Hospitalar Vila Nova de Gaia,Immuno

[10] CUF Porto Hospital,Gastroenterology

[11] Hospital Clínic,Department of Gastroenterology

[12] Universitat of Valencia,Department of Medicine

[13] Valld’Hebron Institut de Recerca VHIR,Motility and Functional Gut Disorders Unit

[14] Hospital Universitari Vall d’Hebron,undefined

[15] Universitat Autònoma de Barcelona,undefined

[16] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd),undefined

[17] University Hospital Germans Trias i Pujol,undefined

来源：

Advances in Therapy | 2017年 / 34卷

关键词：

Abdominal pain; Bloating; Constipation; Constipation-predominant irritable bowel syndrome; Gastroenterology; Linaclotide; Patient management; Recommendations;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：587 / 598

页数：11

共 50 条

[1] Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report
Rey, Enrique
Mearin, Fermin
Alcedo, Javier
Ciriza, Constanza
Delgado-Aros, Silvia
Freitas, Teresa
Mascarenhas, Miguel
Minguez, Miguel
Santos, Javier
Serra, Jordi
ADVANCES IN THERAPY, 2017, 34 (03) : 587 - 598
[2] Advances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotide
Yu, Siegfried W. B.
Rao, Satish S. C.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2014, 7 (05): : 193 - 205
[3] Linaclotide in constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: a profile of its use in the USA
McKeage K.
Lyseng-Williamson K.A.
Drugs & Therapy Perspectives, 2017, 33 (11) : 497 - 504
[4] Linaclotide, Novel Therapy for the Treatment of Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome
Maria I. Vazquez-Roque
Ernest P. Bouras
Advances in Therapy, 2013, 30 : 203 - 211
[5] Linaclotide, Novel Therapy for the Treatment of Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome
Vazquez-Roque, Maria I.
Bouras, Ernest P.
ADVANCES IN THERAPY, 2013, 30 (03) : 203 - 211
[6] Tenapanor for constipation-predominant irritable bowel syndrome
Siddiqui, S.
Cash, B. D.
DRUGS OF TODAY, 2020, 56 (03) : 203 - 210
[7] LubiprostoneIn Constipation-Predominant Irritable Bowel Syndrome
Natalie J. Carter
Lesley J. Scott
Drugs, 2009, 69 : 1229 - 1237
[8] Lubiprostone In Constipation-Predominant Irritable Bowel Syndrome
Carter, Natalie J.
Scott, Lesley J.
DRUGS, 2009, 69 (09) : 1229 - 1237
[9] Tegaserod for constipation-predominant irritable bowel syndrome
Kale-Pradhan, Pramodini B.
Wilhelm, Sheila M.
PHARMACOTHERAPY, 2007, 27 (02): : 267 - 277
[10] Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome
Andresen, Viola
Camilleri, Michael
Busciglio, Irene A.
Grudell, April
Burton, Duane
Mckinzie, Sanna
Foxx-Orenstein, Amy
Kurtz, Caroline B.
Sharma, Vineeta
Johnston, Jeffrey M.
Currie, Mark G.
Zinsmeister, Alan R.
GASTROENTEROLOGY, 2007, 133 (03) : 761 - 768

← 1 2 3 4 5 →